Skip to main content

Table 3 Pain scoring

From: Programmed intermittent epidural bolus versus continuous epidural infusion for postoperative analgesia after major abdominal and gynecological cancer surgery: a randomized, triple-blinded clinical trial

 

Group CEI (n = 40)

Group PIEB (n = 44)

p-value

NRS rest d0

0 (0–0)

0 (0–0)

0.21

NRS rest d1

0 (0–3)

0 (0–2.8)

0.94

NRS rest d2

0.5 (0–3)

0 (0–2.5)

0.34

NRS cough d0

0 (0–3)

0 (0–0)

0.06

NRS cough d1

3 (1–6)

3 (0–5)

0.49

NRS cough d2

2.5 (0.5–5.5)

2.5 (0–6)

0.81

NRS movement d0

0 (0–3)

0 (0–0)

0.32

NRS movement d1

3 (1–5.5)

3 (0–4.5)

0.39

NRS movement d2

3 (0–5)

2 (0–4.5)

0.41

Morphine IV d0, mg

5 (5–7.5)

5 (5–5)

0.03

Morphine IV d1, mg

10 (10–10)

10 (10–10)

0.53

Morphine IV d2, mg

10 (10–15)

10 (10–10)

0.94

Morphine IV d0-d2, mg

15 (2.5–22.5)

7.5 (0–20)

0.27

Opioid need d0, yes / no

12/28

16/28

0.54

Opioid need d1, yes / no

18/22

18/26

0.71

Opioid need d2, yes / no

27/13

22/22

0.11

Opioid need d0-d2, yes / no

30/10

29/15

0.37

  1. Values are expressed as the median (25th–75th percentile and as two-sided p-value of the Mann-Whitney –U test. Uncorrected p-values are displayed. Level of significance p < 0.05. No significant differences were found after Bonferroni correction. NRS numeric rating scale, d0–3 postoperative day 0–3, LA local anaesthetic